New Biktarvy spot puts Gilead in top TV-spending ranks, right behind AbbVie and Pfizer
While Humira held its ad spending crown yet again in May, Latuda jumped up to knock Lyrica from the No. 2 spot it's held for the past few months. Sunovion started revving up its Latuda outlays in April, but jacked up spending by 67% in May, according to data from real-time TV ad tracker iSpot.tv. What's … Συνεχίστε να διαβάζετε In May TV spending, Sunovion jumps to 2nd, but AbbVie easily keeps top spot.